Biosimilar adoption is ramping up in the U.S., and biosimilars have already found wide use in Europe since they were first introduced there in 2006. Growing biosimilar adoption, however, do more than chip away at biologics revenue — they often fuel price erosion. An IQVIA report concluded that biosimilar use in Europe enabled €5.7 billion in…
Rani Therapeutics names president of CVS Kidney Care to its board
Robotic drug-delivery pill company Rani Therapeutics Holdings (NSDQ:RANI) has added Lisa Rometty to its board of directors. Rometty is the president of CVS Kidney Care. Previously, she worked as an executive at Syneos Health and IBM Watson Health. “I’m delighted to welcome Lisa to our Board,” said Talat Imran, CEO of Rani Therapeutics, in a statement. “Lisa’s…